API australian pharmaceutical industries limited

re: a value buy. Syringe you probably right and Sigma may want...

  1. 2,525 Posts.
    lightbulb Created with Sketch. 229
    re: a value buy. Syringe you probably right and Sigma may want out. They have enough on their hands at the present time having recently integrated Arrow into their systems and radically changed Customer Service operations.

    No way will the major shareholders or any others take $2.20. I expect API directors to reject Sigmas latest play on Monday and close off discussions and access.

    I believe API can turn it around in 12 months so current SP is a good BUY.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.